These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31792645)

  • 1. Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.
    Tanzer T; Shah S; Benson C; De Monte V; Gore-Jones V; Rossell SL; Dark F; Kisely S; Siskind D; Melo CD
    Psychopharmacology (Berl); 2020 Jan; 237(1):11-19. PubMed ID: 31792645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.
    Kishi T; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):259-68. PubMed ID: 25283510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis.
    Kishi T; Ikuta T; Oya K; Matsunaga S; Matsuda Y; Iwata N
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):748-757. PubMed ID: 29762677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
    Smith RC; Amiaz R; Si TM; Maayan L; Jin H; Boules S; Sershen H; Li C; Ren J; Liu Y; Youseff M; Lajtha A; Guidotti A; Weiser M; Davis JM
    PLoS One; 2016; 11(1):e0143490. PubMed ID: 26730716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline.
    Garcia-Portilla MP; Garcia-Alvarez L; Sarramea F; Galvan G; Diaz-Mesa E; Bobes-Bascaran T; Al-Halabi S; Elizagarate E; Iglesias C; Saiz Martínez PA; Bobes J
    Schizophr Res; 2016 Oct; 176(2-3):272-280. PubMed ID: 27237598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
    Evins AE; Hoeppner SS; Schoenfeld DA; Hoeppner BB; Cather C; Pachas GN; Cieslak KM; Maravic MC
    Schizophr Res; 2017 May; 183():124-129. PubMed ID: 27956009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial.
    Jeon DW; Shim JC; Kong BG; Moon JJ; Seo YS; Kim SJ; Oh MK; Jung DU
    Schizophr Res; 2016 Oct; 176(2-3):206-211. PubMed ID: 27543252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
    Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
    BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T. Kishi and N. Iwata: Varenicline for smoking cessation in people with schizophrenia: systematic review meta-analysis.
    Evins AE; Hong LE; Kelly DL
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):269-70. PubMed ID: 25377170
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Kozak K; Dermody SS; Rabin RA; Zack M; Barr MS; Tyndale RF; George TP
    Schizophr Res; 2018 Jul; 197():562-563. PubMed ID: 28291692
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials.
    Oon-Arom A; Likhitsathain S; Srisurapanont M
    Drug Alcohol Depend; 2019 Dec; 205():107631. PubMed ID: 31678838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.
    Lerman C; Schnoll RA; Hawk LW; Cinciripini P; George TP; Wileyto EP; Swan GE; Benowitz NL; Heitjan DF; Tyndale RF;
    Lancet Respir Med; 2015 Feb; 3(2):131-138. PubMed ID: 25588294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.